These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27128373)

  • 21. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease.
    Torres M; Price SL; Fiol-Deroque MA; Marcilla-Etxenike A; Ahyayauch H; Barceló-Coblijn G; Terés S; Katsouri L; Ordinas M; López DJ; Ibarguren M; Goñi FM; Busquets X; Vitorica J; Sastre M; Escribá PV
    Biochim Biophys Acta; 2014 Jun; 1838(6):1680-92. PubMed ID: 24374316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism.
    Akyol S; Ugur Z; Yilmaz A; Ustun I; Gorti SKK; Oh K; McGuinness B; Passmore P; Kehoe PG; Maddens ME; Green BD; Graham SF
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease: the cholesterol connection.
    Puglielli L; Tanzi RE; Kovacs DM
    Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
    Lim WLF; Huynh K; Chatterjee P; Martins I; Jayawardana KS; Giles C; Mellett NA; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Drew BG; Masters CL; Meikle PJ; Martins RN;
    J Alzheimers Dis; 2020; 76(1):303-315. PubMed ID: 32474467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease.
    Kant S; Stopa EG; Johanson CE; Baird A; Silverberg GD
    Fluids Barriers CNS; 2018 Dec; 15(1):34. PubMed ID: 30541599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid metabolism in Alzheimer's disease.
    Zhu TB; Zhang Z; Luo P; Wang SS; Peng Y; Chu SF; Chen NH
    Brain Res Bull; 2019 Jan; 144():68-74. PubMed ID: 30472149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Signaling Lipid Associated with Alzheimer's Disease Promotes Mitochondrial Dysfunction.
    Kennedy MA; Moffat TC; Gable K; Ganesan S; Niewola-Staszkowska K; Johnston A; Nislow C; Giaever G; Harris LJ; Loewith R; Zaremberg V; Harper ME; Dunn T; Bennett SAL; Baetz K
    Sci Rep; 2016 Jan; 6():19332. PubMed ID: 26757638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipids and Alzheimer's Disease.
    Kao YC; Ho PC; Tu YK; Jou IM; Tsai KJ
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipids and the pathogenesis of Alzheimer's disease: is there a link?
    Mielke MM; Lyketsos CG
    Int Rev Psychiatry; 2006 Apr; 18(2):173-86. PubMed ID: 16777671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.
    Zhao QF; Wan Y; Wang HF; Sun FR; Hao XK; Tan MS; Tan CC; Zhang DQ; Tan L; Yu JT;
    J Alzheimers Dis; 2016 Mar; 52(2):693-703. PubMed ID: 27003212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E and Alzheimer disease.
    Huang Y
    Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes.
    Cossec JC; Marquer C; Panchal M; Lazar AN; Duyckaerts C; Potier MC
    Biochim Biophys Acta; 2010 Aug; 1801(8):839-45. PubMed ID: 20348021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
    Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
    Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease.
    Liao F; Yoon H; Kim J
    Curr Opin Lipidol; 2017 Feb; 28(1):60-67. PubMed ID: 27922847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition.
    Ooi KM; Vacy K; Boon WC
    Neurochem Int; 2021 Oct; 149():105143. PubMed ID: 34311029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.